Skip to main content
Top
Published in: Reviews in Endocrine and Metabolic Disorders 3/2020

01-09-2020 | Obesity

Acute assessment of subjective appetite and implicated hormones after a hypnosis-induced hallucinated meal: a randomized cross-over pilot trial

Authors: Iolanda Cioffi, Roberto Gambino, Rosalba Rosato, Bice Properzi, Giuseppe Regaldo, Valentina Ponzo, Marianna Pellegrini, Franco Contaldo, Fabrizio Pasanisi, Ezio Ghigo, Simona Bo

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 3/2020

Login to get access

Abstract

The use of hypnosis can generate hallucinatory phenomena, which ranged from vivid/auditory imagery to fully developed “hallucinations” in selected people. The aim of this pilot trial was investigating the acute effects of a hypnosis-induced hallucinated breakfast (HB) compared to those of a real breakfast (RB) on subjective appetite and appetite-regulating hormones in highly hypnotizable individuals. Eight healthy post-menopausal women were recruited to consume two meals: the HB and the RB in a randomized crossover design. Participants underwent appetite sensations measurements (before meal and each 30-min until 270-min) and blood sample collection (at 0, 20, 60, 90, 180-min). A 3-day food-record was filled after each meal. The adjusted repeated measures ANCOVA did not show any meal×time interactions on subjective appetite postprandially. As expected, significantly higher glucose (p < 0.001), insulin (p < 0.001), and lower free fatty acid (p < 0.001) concentrations were found after the RB, but not following HB. Furthermore, RB significantly increased postprandial levels of glucagon-like-peptide-1 and peptide-YY at 20, 60, 90 and 180-min, whereas acylated-ghrelin and leptin levels did not differ. Postprandial neuropeptide-Y and orexin-A values significantly increased at different time-points after RB, but not following HB, while α-melanocyte-stimulating hormone levels enhanced after HB only. Energy intakes were significantly lower after HB on the test-day only (HB = 1146.6 ± 343.8 vs RB = 1634.7 ± 274.2 kcal/d; p = 0.003). Appetite sensation might be modulated by fully developed meal “hallucination” induced by hypnosis, likely affecting brain-peptides implicated in the appetite regulation. However, further studies are needed to verify these results obtained in a highly selected group of individuals. NCT03934580.
Literature
1.
go back to reference Hopkins M, Blundell J, Halford J, King N, Finlayson G. The regulation of food intake in humans. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al., editors. Endotext [internet]. South Dartmouth: MDText.com, Inc.; 2000. Hopkins M, Blundell J, Halford J, King N, Finlayson G. The regulation of food intake in humans. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al., editors. Endotext [internet]. South Dartmouth: MDText.com, Inc.; 2000.
2.
go back to reference Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, Mela D, Salah S, Schuring E, van der Knaap H, Westerterp M. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010;11:251–70.PubMedPubMedCentral Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, Mela D, Salah S, Schuring E, van der Knaap H, Westerterp M. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010;11:251–70.PubMedPubMedCentral
3.
go back to reference Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med. 2000;32:222–32.PubMed Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med. 2000;32:222–32.PubMed
4.
go back to reference Zanchi D, Depoorter A, Egloff L, Haller S, Mählmann L, Lang UE, Drewe J, Beglinger C, Schmidt A, Borgwardt S. The impact of gut hormones on the neural circuit of appetite and satiety: a systematic review. Neurosci Biobehav Rev. 2017;80:457–75.PubMed Zanchi D, Depoorter A, Egloff L, Haller S, Mählmann L, Lang UE, Drewe J, Beglinger C, Schmidt A, Borgwardt S. The impact of gut hormones on the neural circuit of appetite and satiety: a systematic review. Neurosci Biobehav Rev. 2017;80:457–75.PubMed
5.
go back to reference Coll AP. Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential? Clin Sci. 2007;113:171–82. Coll AP. Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential? Clin Sci. 2007;113:171–82.
6.
go back to reference Williams DL. Neural integration of satiation and food reward: role of GLP-1 and orexin pathways. Physiol Behav. 2014;136:194–9.PubMedPubMedCentral Williams DL. Neural integration of satiation and food reward: role of GLP-1 and orexin pathways. Physiol Behav. 2014;136:194–9.PubMedPubMedCentral
7.
go back to reference Yeomans MR, Blundell JE, Leshem M. Palatability: response to nutritional need or need-free stimulation of appetite? Br J Nutr. 2004;(Suppl 1):S3–14. Yeomans MR, Blundell JE, Leshem M. Palatability: response to nutritional need or need-free stimulation of appetite? Br J Nutr. 2004;(Suppl 1):S3–14.
8.
go back to reference Gumbs MCR, van den Heuvel JK, la Fleur SE. The effect of obesogenic diets on brain Neuropeptide Y. Physiol Behav. 2016;162:161–73.PubMed Gumbs MCR, van den Heuvel JK, la Fleur SE. The effect of obesogenic diets on brain Neuropeptide Y. Physiol Behav. 2016;162:161–73.PubMed
9.
go back to reference Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Ghrelin GN. CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and Glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97:411–63.PubMed Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Ghrelin GN. CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and Glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97:411–63.PubMed
10.
go back to reference Kirsch I. Hypnotic enhancement of cognitive-behavioral weight loss treatments--another meta-reanalysis. J Consult Clin Psychol. 1996;64:517–9.PubMed Kirsch I. Hypnotic enhancement of cognitive-behavioral weight loss treatments--another meta-reanalysis. J Consult Clin Psychol. 1996;64:517–9.PubMed
11.
go back to reference Pittler MH, Ernst E. Complementary therapies for reducing body weight: a systematic review. Int J Obes. 2005;29:1030–8. Pittler MH, Ernst E. Complementary therapies for reducing body weight: a systematic review. Int J Obes. 2005;29:1030–8.
12.
go back to reference Bo S, Rahimi F, Goitre I, Properzi B, Ponzo V, Regaldo G, Boschetti S, Fadda M, Ciccone G, Abbate Daga G, Mengozzi G, Evangelista A, de Francesco A, Belcastro S, Broglio F. Effects of self-conditioning techniques (self-hypnosis) in promoting weight loss in patients with severe obesity: a randomized controlled trial. Obesity. 2018;26:1422–9.PubMed Bo S, Rahimi F, Goitre I, Properzi B, Ponzo V, Regaldo G, Boschetti S, Fadda M, Ciccone G, Abbate Daga G, Mengozzi G, Evangelista A, de Francesco A, Belcastro S, Broglio F. Effects of self-conditioning techniques (self-hypnosis) in promoting weight loss in patients with severe obesity: a randomized controlled trial. Obesity. 2018;26:1422–9.PubMed
13.
go back to reference Entwistle PA, Webb RJ, Abayomi JC, Johnson B, Sparkes AC, Davies IG. Unconscious agendas in the etiology of refractory obesity and the role of hypnosis in their identification and resolution: a new paradigm for weight-management programs or a paradigm revisited? Int J Clin Exp Hypn. 2014;62:330–59.PubMed Entwistle PA, Webb RJ, Abayomi JC, Johnson B, Sparkes AC, Davies IG. Unconscious agendas in the etiology of refractory obesity and the role of hypnosis in their identification and resolution: a new paradigm for weight-management programs or a paradigm revisited? Int J Clin Exp Hypn. 2014;62:330–59.PubMed
14.
go back to reference Chiarioni G, Vantini I, De Iorio F, Benini L. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Aliment Pharmacol Ther. 2006;23:1241–9.PubMed Chiarioni G, Vantini I, De Iorio F, Benini L. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Aliment Pharmacol Ther. 2006;23:1241–9.PubMed
15.
go back to reference Klein KB, Spiegel D. Modulation of gastric acid secretion by hypnosis. Gastroenterology. 1989;96:1383–7.PubMed Klein KB, Spiegel D. Modulation of gastric acid secretion by hypnosis. Gastroenterology. 1989;96:1383–7.PubMed
16.
go back to reference Lea R, Houghton LA, Calvert EL, Larder S, Gonsalkorale WM, Whelan V, Randles J, Cooper P, Cruickshanks P, Miller V, Whorwell PJ. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17:635–42.PubMed Lea R, Houghton LA, Calvert EL, Larder S, Gonsalkorale WM, Whelan V, Randles J, Cooper P, Cruickshanks P, Miller V, Whorwell PJ. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17:635–42.PubMed
17.
go back to reference Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet. 1984;2:1232–4.PubMed Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet. 1984;2:1232–4.PubMed
18.
go back to reference Enck P, Hefner J, Herbert BM, Mazurak N, Weimer K, Muth ER, et al. Sensitivity and specificity of hypnosis effects on gastric myoelectrical activity. Gray M, editor. PLoS ONE. 2013;8:e83486.PubMedPubMedCentral Enck P, Hefner J, Herbert BM, Mazurak N, Weimer K, Muth ER, et al. Sensitivity and specificity of hypnosis effects on gastric myoelectrical activity. Gray M, editor. PLoS ONE. 2013;8:e83486.PubMedPubMedCentral
19.
go back to reference Siddi S, Ochoa S, Laroi F, Cella M, Raballo A, Saldivia S, Quijada Y, Laloyaux J, Rocha NB, Lincoln TM, Schlier B, Ntouros E, Bozikas VP, Gawęda Ł, Machado S, Nardi AE, Rodante D, Deshpande SN, Haro JM, Preti A. A cross-national investigation of hallucination-like experiences in 10 countries: the E-CLECTIC study. Schizophr Bull. 2019;45:S43–S55.PubMedPubMedCentral Siddi S, Ochoa S, Laroi F, Cella M, Raballo A, Saldivia S, Quijada Y, Laloyaux J, Rocha NB, Lincoln TM, Schlier B, Ntouros E, Bozikas VP, Gawęda Ł, Machado S, Nardi AE, Rodante D, Deshpande SN, Haro JM, Preti A. A cross-national investigation of hallucination-like experiences in 10 countries: the E-CLECTIC study. Schizophr Bull. 2019;45:S43–S55.PubMedPubMedCentral
20.
go back to reference Giuseppe Regaldo. Manuale di ipnosi medica rapida. 2014. Giuseppe Regaldo. Manuale di ipnosi medica rapida. 2014.
21.
go back to reference Shor RE, Orne EC. Norms on the Harvard group scale of hypnotic susceptibility, form a. Int J Clin Exp Hypn. 1963;11:39–47.PubMed Shor RE, Orne EC. Norms on the Harvard group scale of hypnotic susceptibility, form a. Int J Clin Exp Hypn. 1963;11:39–47.PubMed
22.
go back to reference Bowers KS. Waterloo-Stanford group scale of hypnotic susceptibility, form C: manual and response booklet. Int J Clin Exp Hypn. 1998;46:250–68.PubMed Bowers KS. Waterloo-Stanford group scale of hypnotic susceptibility, form C: manual and response booklet. Int J Clin Exp Hypn. 1998;46:250–68.PubMed
23.
go back to reference Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000;24:38–48.PubMed Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000;24:38–48.PubMed
24.
go back to reference Katschinski M, Dahmen G, Reinshagen M, Beglinger C, Koop H, Nustede R, Adler G. Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Gastroenterology. 1992;103:383–91.PubMed Katschinski M, Dahmen G, Reinshagen M, Beglinger C, Koop H, Nustede R, Adler G. Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Gastroenterology. 1992;103:383–91.PubMed
25.
go back to reference Spiegel D. Negative and positive visual hypnotic hallucinations: attending inside and out. Int J Clin Exp Hypn. 2003;51:130–46.PubMed Spiegel D. Negative and positive visual hypnotic hallucinations: attending inside and out. Int J Clin Exp Hypn. 2003;51:130–46.PubMed
26.
go back to reference Ferrario CR, Labouèbe G, Liu S, Nieh EH, Routh VH, Xu S, O'Connor EC. Homeostasis meets motivation in the battle to control food intake. J Neurosci. 2016;36:11469–81.PubMedPubMedCentral Ferrario CR, Labouèbe G, Liu S, Nieh EH, Routh VH, Xu S, O'Connor EC. Homeostasis meets motivation in the battle to control food intake. J Neurosci. 2016;36:11469–81.PubMedPubMedCentral
27.
go back to reference Sakurai T. Roles of orexins in the regulation of body weight homeostasis. Obes Res Clin Pract. 2014;8:e414–20.PubMed Sakurai T. Roles of orexins in the regulation of body weight homeostasis. Obes Res Clin Pract. 2014;8:e414–20.PubMed
28.
go back to reference Morello G, Imperatore R, Palomba L, Finelli C, Labruna G, Pasanisi F, Sacchetti L, Buono L, Piscitelli F, Orlando P, di Marzo V, Cristino L. Orexin-a represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling. Proc Natl Acad Sci U S A. 2016;113:4759–64.PubMedPubMedCentral Morello G, Imperatore R, Palomba L, Finelli C, Labruna G, Pasanisi F, Sacchetti L, Buono L, Piscitelli F, Orlando P, di Marzo V, Cristino L. Orexin-a represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling. Proc Natl Acad Sci U S A. 2016;113:4759–64.PubMedPubMedCentral
29.
go back to reference Imperatore R, Palomba L, Cristino L. Role of Orexin-a in hypertension and obesity. Curr Hypertens Rep. 2017;19:34.PubMed Imperatore R, Palomba L, Cristino L. Role of Orexin-a in hypertension and obesity. Curr Hypertens Rep. 2017;19:34.PubMed
30.
go back to reference Goforth PB, Myers MG. Roles for Orexin/Hypocretin in the control of energy balance and metabolism. Curr Top Behav Neurosci. 2017;33:137–56.PubMed Goforth PB, Myers MG. Roles for Orexin/Hypocretin in the control of energy balance and metabolism. Curr Top Behav Neurosci. 2017;33:137–56.PubMed
31.
go back to reference Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: Orexins and Neuromedins. In: Joost H-G, editor. Appetite control. Berlin: Springer. p. 2012, 77–109. Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: Orexins and Neuromedins. In: Joost H-G, editor. Appetite control. Berlin: Springer. p. 2012, 77–109.
32.
go back to reference Yi M, Li H, Wu Z, Yan J, Liu Q, Ou C, Chen M. A promising therapeutic target for metabolic diseases: neuropeptide Y receptors in humans. Cell Physiol Biochem. 2018;45:88–107.PubMed Yi M, Li H, Wu Z, Yan J, Liu Q, Ou C, Chen M. A promising therapeutic target for metabolic diseases: neuropeptide Y receptors in humans. Cell Physiol Biochem. 2018;45:88–107.PubMed
33.
go back to reference Muroi Y, Ishii T. A novel neuropeptide Y neuronal pathway linking energy state and reproductive behavior. Neuropeptides. 2016;59:1–8.PubMed Muroi Y, Ishii T. A novel neuropeptide Y neuronal pathway linking energy state and reproductive behavior. Neuropeptides. 2016;59:1–8.PubMed
34.
go back to reference Mercer RE, Chee MJS, Colmers WF. The role of NPY in hypothalamic mediated food intake. Front Neuroendocrinol. 2011;32:398–415.PubMed Mercer RE, Chee MJS, Colmers WF. The role of NPY in hypothalamic mediated food intake. Front Neuroendocrinol. 2011;32:398–415.PubMed
35.
go back to reference Holst JJ. Incretin hormones and the satiation signal. Int J Obes. 2013;37:1161–8. Holst JJ. Incretin hormones and the satiation signal. Int J Obes. 2013;37:1161–8.
36.
go back to reference van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol. 2014;221:T1–16.PubMed van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol. 2014;221:T1–16.PubMed
37.
go back to reference Stadlbauer U, Woods SC, Langhans W, Meyer U. PYY3-36: beyond food intake. Front Neuroendocrinol. 2015;38:1–11.PubMed Stadlbauer U, Woods SC, Langhans W, Meyer U. PYY3-36: beyond food intake. Front Neuroendocrinol. 2015;38:1–11.PubMed
38.
go back to reference Gibbons C, Caudwell P, Finlayson G, Webb D-L, Hellström PM, Näslund E, Blundell JE. Comparison of postprandial profiles of ghrelin, active GLP-1, and Total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety. J Clin Endocrinol Metab. 2013;98:E847–55.PubMed Gibbons C, Caudwell P, Finlayson G, Webb D-L, Hellström PM, Näslund E, Blundell JE. Comparison of postprandial profiles of ghrelin, active GLP-1, and Total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety. J Clin Endocrinol Metab. 2013;98:E847–55.PubMed
39.
go back to reference Broglio F, Arvat E, Benso A, Gottero C, Prodam F, Granata R, Papotti M, Muccioli G, Deghenghi R, Ghigo E. Ghrelin: much more than a natural growth hormone secretagogue. Isr Med Assoc J. 2002;4:607–13.PubMed Broglio F, Arvat E, Benso A, Gottero C, Prodam F, Granata R, Papotti M, Muccioli G, Deghenghi R, Ghigo E. Ghrelin: much more than a natural growth hormone secretagogue. Isr Med Assoc J. 2002;4:607–13.PubMed
40.
go back to reference Harris RBS. Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2014;1842:414–23. Harris RBS. Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2014;1842:414–23.
41.
42.
go back to reference Oswal A, Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity. 2010;18:221–9.PubMed Oswal A, Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity. 2010;18:221–9.PubMed
43.
go back to reference Cristino L, Busetto G, Imperatore R, Ferrandino I, Palomba L, Silvestri C, Petrosino S, Orlando P, Bentivoglio M, Mackie K, di Marzo V. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc Natl Acad Sci. 2013;110:E2229–38.PubMedPubMedCentral Cristino L, Busetto G, Imperatore R, Ferrandino I, Palomba L, Silvestri C, Petrosino S, Orlando P, Bentivoglio M, Mackie K, di Marzo V. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc Natl Acad Sci. 2013;110:E2229–38.PubMedPubMedCentral
44.
go back to reference Yeo GSH. Genetics of obesity: can an old dog teach us new tricks? Diabetologia. 2017;60(5):778–83.PubMed Yeo GSH. Genetics of obesity: can an old dog teach us new tricks? Diabetologia. 2017;60(5):778–83.PubMed
45.
go back to reference Zhu P, Sun W, Zhang C, Song Z, Lin S. The role of neuropeptide Y in the pathophysiology of atherosclerotic cardiovascular disease. Int J Cardiol. 2016;220:235–41.PubMed Zhu P, Sun W, Zhang C, Song Z, Lin S. The role of neuropeptide Y in the pathophysiology of atherosclerotic cardiovascular disease. Int J Cardiol. 2016;220:235–41.PubMed
46.
go back to reference Cintron D, Beckman JP, Bailey KR, Lahr BD, Jayachandran M, Miller VM. Plasma orexin a levels in recently menopausal women during and 3 years following use of hormone therapy. Maturitas. 2017;99:59–65.PubMedPubMedCentral Cintron D, Beckman JP, Bailey KR, Lahr BD, Jayachandran M, Miller VM. Plasma orexin a levels in recently menopausal women during and 3 years following use of hormone therapy. Maturitas. 2017;99:59–65.PubMedPubMedCentral
47.
go back to reference Jiang H, White MP, Greicius MD, Waelde LC, Spiegel D. Brain activity and functional connectivity associated with hypnosis. Cereb Cortex. 2017;27:4083–93.PubMed Jiang H, White MP, Greicius MD, Waelde LC, Spiegel D. Brain activity and functional connectivity associated with hypnosis. Cereb Cortex. 2017;27:4083–93.PubMed
Metadata
Title
Acute assessment of subjective appetite and implicated hormones after a hypnosis-induced hallucinated meal: a randomized cross-over pilot trial
Authors
Iolanda Cioffi
Roberto Gambino
Rosalba Rosato
Bice Properzi
Giuseppe Regaldo
Valentina Ponzo
Marianna Pellegrini
Franco Contaldo
Fabrizio Pasanisi
Ezio Ghigo
Simona Bo
Publication date
01-09-2020
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 3/2020
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-020-09559-4

Other articles of this Issue 3/2020

Reviews in Endocrine and Metabolic Disorders 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.